BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8839647)

  • 1. Colonization and infection with Moraxella catarrhalis in childhood.
    Berner R; Schumacher RF; Brandis M; Forster J
    Eur J Clin Microbiol Infect Dis; 1996 Jun; 15(6):506-9. PubMed ID: 8839647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance, isolation, identification and sensitivity of Branhaemella (moraxella) catarrhalis.
    Hafiz S; Hafiz T; Yazdani I
    J Pak Med Assoc; 1993 Aug; 43(8):153-4. PubMed ID: 8264093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Moraxella (Branhamella) catarrhalis as a respiratory pathogen in children.
    Korppi M; Katila ML; Jääskeläinen J; Leinonen M
    Acta Paediatr; 1992 Dec; 81(12):993-6. PubMed ID: 1290865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchopulmonary infection with Moraxella catarrhalis in infants requiring extracorporeal membrane oxygenation.
    Fenton AC; Foweraker JE; Pearson GA; Firmin RK
    Pediatr Pulmonol; 1994 Jun; 17(6):393-5. PubMed ID: 8090611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
    Enright MC; McKenzie H
    J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children with persistent cough--outcome with treatment and role of Moraxella catarrhalis?
    Gottfarb P; Brauner A
    Scand J Infect Dis; 1994; 26(5):545-51. PubMed ID: 7710536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Branhamella (Moraxella) catarrhalis--a clinically relevant pathogen of bronchopulmonary diseases?].
    Radzuweit S; Kalich R
    Z Erkr Atmungsorgane; 1991; 177(1-2):82-7. PubMed ID: 1808857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of Moraxella catarrhalis in patients at King Khalid University Hospital, Riyadh.
    Babay HA
    Saudi Med J; 2000 Sep; 21(9):860-3. PubMed ID: 11376364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moraxella (Branhamella) catarrhalis: clinical, microbiological and immunological features in lower respiratory tract infections.
    Christensen JJ
    APMIS Suppl; 1999; 88():1-36. PubMed ID: 10189833
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections].
    Bourgeois F; Lambert-Zechovsky N; Bingen E
    Pathol Biol (Paris); 1993 Jun; 41(6):555-61. PubMed ID: 8247636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A; Janicka G; Krawiecka D; Kochanowska J
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower respiratory tract infection due to ciprofloxacin resistant Moraxella catarrhalis.
    Cunliffe NA; Emmanuel FX; Thomson CJ
    J Antimicrob Chemother; 1995 Jul; 36(1):273-4. PubMed ID: 8537282
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythromycin treatment is beneficial for longstanding Moraxella catarrhalis associated cough in children.
    Darelid J; Löfgren S; Malmvall BE
    Scand J Infect Dis; 1993; 25(3):323-9. PubMed ID: 8362228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrent respiratory tract infection caused by Moraxella catarrhalis in patients with pneumoconiosis].
    Omori A; Yoshida T; Furukawa K; Takahashi A; Mochinaga S; Nagatake T
    Kansenshogaku Zasshi; 1999 Apr; 73(4):311-7. PubMed ID: 10356888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of respiratory tract pathogens and antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated between 1990 and 1993.
    Nishioka K; Ogihara H; Ohno I; Tanno Y; Shirato K
    Tohoku J Exp Med; 1996 Jun; 179(2):111-21. PubMed ID: 8875767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Branhamella catarrhalis as a disease pathogen].
    Simon C
    Fortschr Med; 1991 Jul; 109(22):447-8. PubMed ID: 1937324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in children with acute respiratory infection with or without nasopharyngeal bacterial carriage.
    Andrade DC; Borges IC; Bouzas ML; Oliveira JR; Käyhty H; Ruuskanen O; Nascimento-Carvalho C
    Infect Dis (Lond); 2018 Sep; 50(9):705-713. PubMed ID: 29688138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.
    Thornsberry C; Jones ME; Hickey ML; Mauriz Y; Kahn J; Sahm DF
    J Antimicrob Chemother; 1999 Dec; 44(6):749-59. PubMed ID: 10590275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Tween-80 test in the identification of Moraxella catarrhalis].
    Vírseda I; Borrajo E; Ballestero S; Pozuelo MJ; Meseguer MA
    Enferm Infecc Microbiol Clin; 1993 Feb; 11(2):116. PubMed ID: 8481437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.